{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:41:15Z","timestamp":1792608075533,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>The clinical course of primary sclerosing cholangitis (PSC)-associated inflammatory bowel disease (IBD) after liver transplantation (LTx) varies significantly across studies. This meta-analysis aims to provide a comprehensive estimation of incidence rates (IR) for IBD-related outcomes and PSC recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Online databases (January 2000-June 2025) were searched for studies on PSC patients with or without IBD at LTx. Studies reporting posttransplant outcomes of interest were included. The pooled IR were calculated with the \u201cmeta\u201d package (R Studio [V.4.3.2]) using a random effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      A total of 34 studies (3828 patients; 67% with IBD at transplantation) were included. The IR of preexiting IBD exacerbation was 36.1 per 1000 person-years (95% confidence intervals [CI], 23.0-56.5). Medically refractory IBD requiring colectomy occurred at an IR of 12.4 per 1000 person-years (95% CI, 8.9-17.4). The IRs of colorectal neoplasia and advanced neoplasia were 10.3 (95% CI, 6.4-16.7) and 7.7 (95% CI, 5.6-10.7) per 1000 person-years, respectively. Among posttransplant PSC-only patients, the IR of newly diagnosed IBD was 20.0 (95% CI, 12.0-33.4). PSC recurrence occurred more frequently in PSC-IBD patients (31.9; 95% CI, 25.0-40.5) than in PSC-only patients (21.4; 95% CI, 11.3-40.6), corresponding to an incidence rate ratio of 2.16 (95% CI, 1.72-2.72;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>After LTx for PSC, patients remain at substantial risk of colorectal neoplasia and de novo IBD. PSC-IBD is associated with a higher risk of disease recurrence. These findings support continued endoscopic surveillance and close monitoring of IBD activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005894","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:00:11Z","timestamp":1792605611000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Patients With Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis: A Systematic Review and Meta-analysis"],"prefix":"10.1097","author":[{"given":"Jiangrong","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Sneek","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."},{"name":"Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"den Hoed","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan J.","family":"van der Meer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."},{"name":"Erasmus MC Transplant Institute, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie C.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"R1-20261021","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/ibd\/izad276","article-title":"Incidence and prevalence of primary sclerosing cholangitis: a meta-analysis of population-based studies.","volume":"30","author":"Cooper","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"R2-20261021","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis.","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"R3-20261021","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.dld.2024.01.175","article-title":"Trends in liver transplantation for primary sclerosing cholangitis.","volume":"56","author":"Morelli","year":"2024","journal-title":"Dig Liver Dis"},{"key":"R4-20261021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster","year":"2024","journal-title":"J Hepatol"},{"key":"R5-20261021","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis.","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"R6-20261021","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary Sclerosing cholangitis predicts poorer clinical outcomes.","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"R7-20261021","doi-asserted-by":"crossref","first-page":"510","DOI":"10.6002\/ect.2013.0051","article-title":"Survival without biliary complications after liver transplant for primary sclerosing cholangitis.","volume":"11","author":"Mogl","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"R8-20261021","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/MIB.0000000000001105","article-title":"Clinical course of ulcerative colitis after liver transplantation in patients with concomitant primary sclerosing cholangitis and ulcerative colitis.","volume":"23","author":"Fattahi","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"R9-20261021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","article-title":"The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.","volume":"33","author":"Joshi","year":"2013","journal-title":"Liver Int"},{"key":"R10-20261021","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R12-20261021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"R13-20261021","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10350-004-7291-9","article-title":"Outcome of patients undergoing liver transplantation for primary sclerosing cholangitis.","volume":"46","author":"MacLean","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"R14-20261021","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00042737-200306000-00013","article-title":"Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis.","volume":"15","author":"van de Vrie","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-20261021","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00042737-200512000-00018","article-title":"The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation.","volume":"17","author":"Ho","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-20261021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/lt.21077","article-title":"Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.","volume":"13","author":"Cholongitas","year":"2007","journal-title":"Liver Transpl"},{"key":"R17-20261021","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s11605-008-0528-5","article-title":"Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis.","volume":"12","author":"Cho","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R18-20261021","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cgh.2007.09.018","article-title":"Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis.","volume":"6","author":"Freeman","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R19-20261021","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bjs.6210","article-title":"Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis.","volume":"95","author":"Mathis","year":"2008","journal-title":"Br J Surg"},{"key":"R20-20261021","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.transproceed.2009.03.027","article-title":"Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.","volume":"41","author":"Bosso","year":"2009","journal-title":"Transplant Proc"},{"key":"R21-20261021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.","volume":"24","author":"Moncrief","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"R22-20261021","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/lt.22320","article-title":"Pediatric liver transplantation for primary sclerosing cholangitis.","volume":"17","author":"Miloh","year":"2011","journal-title":"Liver Transpl"},{"key":"R23-20261021","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ibd.21692","article-title":"Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.","volume":"18","author":"Hanouneh","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R24-20261021","first-page":"434","article-title":"The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease.","volume":"9","author":"Mosli","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"R25-20261021","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol"},{"key":"R26-20261021","doi-asserted-by":"crossref","first-page":"e0135807","DOI":"10.1371\/journal.pone.0135807","article-title":"Solid organ transplantation in patients with Inflammatory Bowel Diseases (IBD): analysis of transplantation outcome and IBD activity in a large single center cohort.","volume":"10","author":"Schnitzler","year":"2015","journal-title":"PLoS One"},{"key":"R27-20261021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/lt.24350","article-title":"Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis.","volume":"22","author":"Hildebrand","year":"2016","journal-title":"Liver Transpl"},{"key":"R28-20261021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/apt.14828","article-title":"The impact of ileal pouch-anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis.","volume":"48","author":"Trivedi","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-20261021","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.dld.2020.02.006","article-title":"Does mucosal inflammation drive recurrence of primary sclerosing cholangitis in liver transplantion recipients with ulcerative colitis?","volume":"52","author":"Dekkers","year":"2020","journal-title":"Dig Liver Dis"},{"key":"R30-20261021","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/lt.25838","article-title":"Impact of preexisting inflammatory bowel disease on the outcome of liver transplantation for primary sclerosing cholangitis.","volume":"26","author":"Irles-Depe","year":"2020","journal-title":"Liver Transpl"},{"key":"R31-20261021","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jceh.2020.02.002","article-title":"Good long-term outcomes in patients with primary sclerosing cholangitis undergoing living donor liver transplantation.","volume":"10","author":"Choudhary","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"R32-20261021","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.transproceed.2020.09.011","article-title":"The course of ulcerative colitis after pediatric liver transplantation for Sclerosing cholangitis.","volume":"53","author":"Osiecki","year":"2021","journal-title":"Transplant Proc"},{"key":"R33-20261021","doi-asserted-by":"crossref","first-page":"100599","DOI":"10.1016\/j.jhepr.2022.100599","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study.","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"key":"R34-20261021","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1097\/TP.0000000000004563","article-title":"Intestinal bacteremia after liver transplantation is a risk factor for recurrence of primary Sclerosing cholangitis.","volume":"107","author":"Mammadov","year":"2023","journal-title":"Transplantation"},{"key":"R35-20261021","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/SLA.0000000000006041","article-title":"Ileal pouch-anal anastomosis in Primary Sclerosing Cholangitis-inflammatory Bowel Disease (PSC-IBD): long-term pouch and liver transplant outcomes.","volume":"278","author":"Maspero","year":"2023","journal-title":"Ann Surg"},{"key":"R36-20261021","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3390\/jcm12103405","article-title":"Transplantation for primary Sclerosing cholangitis: outcomes and recurrence.","volume":"12","author":"Saner","year":"2023","journal-title":"J Clin Med"},{"key":"R37-20261021","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/jpm14030222","article-title":"Risk factors for recurrence of primary Sclerosing cholangitis after liver transplantation: single-center data.","volume":"14","author":"Catanzaro","year":"2024","journal-title":"J Pers Med"},{"key":"R38-20261021","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/SLA.0000000000006533","article-title":"Long-term outcomes following colectomy and liver transplantation for inflammatory bowel disease with primary Sclerosing cholangitis.","volume":"283","author":"Matar","year":"2024","journal-title":"Ann Surg"},{"key":"R39-20261021","doi-asserted-by":"crossref","first-page":"e70002","DOI":"10.1111\/ctr.70002","article-title":"Recurrence of primary Sclerosing cholangitis and de novo Cholangiocarcinoma after liver transplantation: results from the brazilian cholestasis consortium.","volume":"38","author":"Bittencourt","year":"2024","journal-title":"Clin Transplant"},{"key":"R40-20261021","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10151-024-02976-6","article-title":"Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis.","volume":"28","author":"Schabl","year":"2024","journal-title":"Tech Coloproctol"},{"key":"R41-20261021","doi-asserted-by":"crossref","first-page":"e70078","DOI":"10.1111\/petr.70078","article-title":"Recurrence of primary Sclerosing cholangitis after pediatric liver transplantation: a single-center, retrospective study in Japan.","volume":"29","author":"Vorasittha","year":"2025","journal-title":"Pediatr Transplant"},{"key":"R42-20261021","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1093\/ecco-jcc\/jjx002.101","article-title":"DOP064 High rate of advanced neoplasia after detection of low-grade dysplasia in inflammatory bowel disease patients with primary sclerosing cholangitis.","volume":"11","author":"Ten Hove","year":"2017","journal-title":"J Crohns Colitis"},{"key":"R43-20261021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cgh.2025.02.024","article-title":"Liver transplantation is associated with a reduced risk of colorectal dysplasia in patients with IBD and concomitant PSC.","volume":"24","author":"Coelho-Prabhu","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R44-20261021","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cgh.2012.01.006","article-title":"Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.","volume":"10","author":"Navaneethan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R45-20261021","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0959-8049(95)00216-6","article-title":"Role of bile acids in colorectal carcinogenesis.","volume":"31A","author":"Nagengast","year":"1995","journal-title":"Eur J Cancer"},{"key":"R46-20261021","doi-asserted-by":"crossref","first-page":"101097","DOI":"10.1016\/j.lanepe.2024.101097","article-title":"Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study.","volume":"47","author":"Sarter","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"R47-20261021","first-page":"279","article-title":"A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.","volume":"92","author":"Riley","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R48-20261021","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1038\/s41591-025-03692-w","article-title":"T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis.","volume":"31","author":"ElAbd","year":"2025","journal-title":"Nat Med"},{"key":"R49-20261021","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1600-6143.2006.01333.x","article-title":"Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.","volume":"6","author":"Verdonk","year":"2006","journal-title":"Am J Transplant"},{"key":"R50-20261021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.2003.01613.x","article-title":"Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.","volume":"18","author":"Haagsma","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R51-20261021","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ecco-jcc\/jjab025","article-title":"Systematic review and meta-analysis of outcomes after Ileal pouch-anal anastomosis in primary Sclerosing cholangitis and ulcerative colitis.","volume":"15","author":"Barnes","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R52-20261021","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrgastro.2012.58","article-title":"Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.","volume":"9","author":"Shen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R53-20261021","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R54-20261021","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.3389\/ti.2023.11729","article-title":"Liver transplantation for Primary Sclerosing Cholangitis (PSC) with or without Inflammatory Bowel Disease (IBD)-A European Society of Organ Transplantation (ESOT) consensus statement.","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl Int"},{"key":"R55-20261021","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"R56-20261021","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis.","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J Hepatol"},{"key":"R57-20261021","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1097\/TP.0000000000005607","article-title":"Management of inflammatory bowel disease associated with primary Sclerosing cholangitis pre- and post-liver transplantation.","volume":"110","author":"de Jong","year":"2026","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:00:18Z","timestamp":1792605618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005894","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"2025-09-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}